Abstract
The IL-2 variant H9T inhibits T cell exhaustion and promotes the induction of T cell stemness by acting as a partial agonist.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 4 |
| Number of pages | 1 |
| Journal | American Journal of Transplantation |
| Volume | 22 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2022 |
ASJC Scopus subject areas
- Immunology and Allergy
- Transplantation
- Pharmacology (medical)